Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more
- 2 February 2012
- journal article
- Published by SAGE Publications in Therapeutic Advances in Neurological Disorders
- Vol. 5 (3), 147-159
- https://doi.org/10.1177/1756285611433772
Abstract
B cells and antibodies constitute an important element in different inflammatory diseases of the central nervous system (CNS). Autoantibodies can serve as a biomarker to identify disease subgroups and may in addition contribute to the pathogenic process. One candidate autoantigen for multiple sclerosis (MS) is myelin oligodendrocyte glycoprotein (MOG). MOG is localized at the outermost surface of myelin in the CNS and has been the focus of extensive research for more than 30 years. Its role as an important autoantigen for T cells and as a target of demyelinating autoantibodies has been established in several variants of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. The literature regarding antibodies to MOG in MS patients is confusing and contradictory. Recent studies, however, have described high levels of antibodies to conformationally correct MOG in pediatric acquired demyelination, both acute disseminated encephalomyelitis (ADEM) and MS. In adult MS, such antibodies are rarely found and then only at low levels. In this review, we summarize key findings from animal models and patient studies, discuss challenges in detecting anti-MOG antibodies in patients and present recent approaches to identifying new autoantigens in MS.This publication has 78 references indexed in Scilit:
- Identification of the Myelin Oligodendrocyte Glycoprotein as a Cellular Receptor for Rubella VirusJournal of Virology, 2011
- Elevated Intrathecal Myelin Oligodendrocyte Glycoprotein Antibodies in Multiple SclerosisArchives of Neurology, 2010
- Age-Dependent B Cell Autoimmunity to a Myelin Surface Antigen in Pediatric Multiple SclerosisThe Journal of Immunology, 2009
- Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis opticaAnnals of Neurology, 2009
- Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cellsThe Journal of Experimental Medicine, 2009
- Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animalsProceedings of the National Academy of Sciences of the United States of America, 2009
- Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Neurofascin as a novel target for autoantibody-mediated axonal injuryThe Journal of Experimental Medicine, 2007
- Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured proteinNature Medicine, 2007
- Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosisProceedings of the National Academy of Sciences of the United States of America, 2006